Achelois Pharmaceuticals is pioneering personalized, non-toxic cancer treatments. To support their innovation in tumor-targeting therapeutics, we built a custom SOP & experiment management app that streamlines cloning and maxi prep batch processes for critical steps in their therapeutic development lifecycle.
Biopharma research teams often struggle with manual documentation, fragmented tools, and scattered email threads, leading to poor traceability, inconsistent SOPs, and delays in research milestones. Over 65% of early-stage pharma R&D teams report inefficiencies due to disconnected batch and protocol management. To support precision cancer therapeutics, this platform streamlines cloning and maxi prep workflows by linking SOPs to execution, enabling real-time tracking, collaborative comments, and audit-ready reporting.
Folio3 Digital Health delivered a web-based platform with step-wise experiment builders, role-based access, automated PDF reporting, and version-controlled SOP publishing. The solution ensures compliance, eliminates workflow silos, and improves collaboration across distributed teams. By digitizing the entire experiment lifecycle, Achelois accelerated drug development, boosted data integrity, and improved operational visibility.
Researchers at Achelois were managing complex scientific protocols manually, using fragmented tools and unstructured documentation. Key challenges included:
We designed and developed a web-based SOP & Experiment Management Application that empowers scientists and QA analysts to plan, execute, track, and document lab experiments with complete visibility and version control.
The platform enables users to:
Create, publish, and reuse Standard Operating Procedures (SOPs)
Execute structured experiments based on defined SOPs
Log real-time inputs, comments, and deviations at every step
Monitor experiment status across lifecycle stages: Draft, In Progress, Completed, Archived
Generate and download detailed PDF reports for compliance and collaboration
